| The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis |
44 |
| Toll-like receptors in the pathogenesis of neuroinflammation |
34 |
| Gut microbiota in neurodegenerative disorders |
32 |
| Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences |
19 |
| Inhibitors of NF-kappa B and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease |
19 |
| Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 year |
18 |
| Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF |
12 |
| Plasmacytoid dendritic cell in immunity and cancer |
12 |
| Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice |
12 |
| Effect of combined exercise training on serum brain-derived neurotrophic factor, suppressors of cytokine signaling 1 and 3 in patients with multiple sclerosis |
11 |
| Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction |
11 |
| Exosomes from adipose-derived stem cells alleviate neural injury caused by microglia activation via suppressing NF-kB and MAPK pathway |
11 |
| Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy |
10 |
| LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients |
10 |
| Infiltrating macrophages are broadly activated at the early stage to support acute skeletal muscle injury repair |
10 |
| Behavioural alterations and morphological changes are attenuated by the lack of TRPA1 receptors in the cuprizone-induced demyelination model in mice |
10 |
| The involvement of neuroinflammation and necroptosis in the hippocampus during vascular dementia |
10 |
| B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients |
10 |
| Fingolimod inhibits brain atrophy and promotes brain-derived neurotrophic factor in an animal model of multiple sclerosis |
10 |
| The production of IL-6 in acute epileptic seizure: A video-EEG study |
10 |
| Functional failure of TLR3 and its signaling components contribute to herpes simplex encephalitis |
9 |
| Microglia are continuously activated in the circumventricular organs of mouse brain |
9 |
| Resveratrol protects hippocampal neurons against cerebral ischemia-reperfusion injury via modulating JAK/ERK/STAT signaling pathway in rats |
9 |
| Dysfunctional RNA binding proteins and stress granules in multiple sclerosis |
9 |
| A case series of PD-1 inhibitor-associated paraneoplastic neurologic syndromes |
9 |
| Niacin modulates macrophage polarization in Parkinson's disease |
9 |
| The role of immune regulatory molecules in multiple sclerosis |
9 |
| Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis |
9 |
| Circular RNAs as a novel layer of regulatory mechanism in multiple sclerosis |
8 |
| Variability in PolyIC induced immune response: Implications for preclinical maternal immune activation models |
8 |
| Rapamycin and fingolimod modulate Treg/Th17 cells in experimental autoimmune encephalomyelitis by regulating the Akt-mTOR and MAPK/ERK pathways |
8 |
| Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission |
8 |
| Elevated expression of granulocyte-macrophage colony-stimulating factor receptor in multiple sclerosis lesions |
8 |
| LGI1 and CASPR2 autoimmunity in children: Systematic literature review and report of a young girl with Morvan syndrome |
8 |
| Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NF kappa B pathway signaling targets in LPS/IFN gamma -activated BV-2 microglia cells |
8 |
| Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis |
8 |
| The immunological response to traumatic brain injury |
8 |
| Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease |
8 |
| MOG antibody seropositive aseptic meningitis: A new clinical phenotype |
8 |
| Associations of postpartum sleep, stress, and depressive symptoms with LPS-stimulated cytokine production among African American and White women |
7 |
| The circulating levels of CD4+t helper cells are higher in bipolar disorder as compared to major depressive disorder |
7 |
| Acute effects of physical exercises on the inflammatory markers of patients with fibromyalgia syndrome: A systematic review |
7 |
| The role of microglia and P2X7 receptors in gliomas |
7 |
| Effect of donepezil on the expression and responsiveness to LPS of CHRNA7 and CHRFAM7A in macrophages: A possible link to the cholinergic anti-inflammatory pathway |
7 |
| Fulminant Anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression |
7 |
| Clinical characteristics of autoimmune GFAP astrocytopathy |
7 |
| Neuroinflammatory responses in experimental and human stroke lesions |
7 |
| IL-17A induces autophagy and promotes microglial neuroinflammation through ATG5 and ATG7 in intracerebral hemorrhage |
7 |
| Crosstalk between cancer and the neuro-immune system |
7 |
| Therapeutic potentials of ginger for treatment of Multiple sclerosis: A review with emphasis on its immunomodulatory, anti-inflammatory and anti-oxidative properties |
7 |
